The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.66	49.67	33.49	14.01	114.3	6
Short-Term Investments	-	-	49.37	59.8	-	-
Cash & Short-Term Investments	27.66	49.67	82.86	73.81	114.3	6
Cash Growth	-41.65%	-40.05%	12.26%	-35.43%	1805.62%	145.20%
Accounts Receivable	59.64	48.34	42.36	39.82	20.01	17.15
Other Receivables	0.34	0.35	0.55	0.62	1.24	0.11
Receivables	59.98	48.68	42.91	40.43	21.24	17.26
Inventory	18.88	10.04	13.68	9.26	6.44	4.35
Prepaid Expenses	3.57	4.03	4.05	6.92	11.2	2.11
Restricted Cash	-	-	-	-	0.88	-
Total Current Assets	110.09	112.42	143.49	130.42	154.06	29.72
Property, Plant & Equipment	33.98	37.67	40.05	33.04	4.19	2.1
Long-Term Investments	-	-	-	58.35	-	-
Goodwill	7.23	7.23	7.23	21.42	26.63	14.23
Other Intangible Assets	11.73	14.81	17.9	17.96	18.25	19.52
Other Long-Term Assets	0.59	0.59	0.56	0.48	0.32	0.12
Total Assets	163.62	172.72	209.24	261.67	203.44	65.69
Accounts Payable	35.63	24.32	14.43	9.37	15.56	12.64
Accrued Expenses	10.74	12.98	10.7	9.42	8.33	4.21
Current Portion of Long-Term Debt	-	-	-	-	0.18	5.37
Current Portion of Leases	7.23	6.84	6.36	5.5	-	-
Current Income Taxes Payable	-	-	-	0.26	0.13	1.14
Current Unearned Revenue	4.9	4.7	1.09	1.14	0.26	3.38
Other Current Liabilities	7.08	3.38	2.21	4.04	5.33	1.86
Total Current Liabilities	65.58	52.22	34.79	29.72	29.8	28.61
Long-Term Debt	76.2	93.13	86.83	80.62	-	6.56
Long-Term Leases	20.2	23.29	26.49	22.06	-	-
Long-Term Deferred Tax Liabilities	-	0.03	0.03	0.11	0.37	1.61
Other Long-Term Liabilities	13.92	0.46	4.08	5.98	69.11	0.81
Total Liabilities	175.89	169.13	152.22	138.49	99.28	37.59
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	252.65	215.41	204.19	186.25	167.39	80.4
Retained Earnings	-263.91	-210.81	-146.15	-63.08	-63.23	-52.31
Treasury Stock	-1.02	-1.02	-1.02	-	-	-
Total Common Equity	-12.27	3.59	57.03	123.18	104.16	28.1
Shareholders' Equity	-12.27	3.59	57.03	123.18	104.16	28.1
Total Liabilities & Equity	163.62	172.72	209.24	261.67	203.44	65.69
Total Debt	103.62	123.25	119.68	108.18	0.18	11.93
Net Cash (Debt)	-75.97	-73.58	-36.82	-34.37	114.12	-5.93
Net Cash Per Share	-0.88	-0.98	-0.50	-0.43	1.72	-0.10
Filing Date Shares Outstanding	98.38	75.75	74.31	74.55	73.25	-
Total Common Shares Outstanding	97.57	75.74	74.15	73.27	73.25	-
Working Capital	44.51	60.2	108.71	100.7	124.26	1.11
Book Value Per Share	-0.13	0.05	0.77	1.68	1.42	-
Tangible Book Value	-31.24	-18.45	31.89	83.8	59.29	-5.64
Tangible Book Value Per Share	-0.32	-0.24	0.43	1.14	0.81	-
Machinery	6.84	6.05	5.84	3.88	2.11	1.21
Construction In Progress	0.99	0.11	1.8	1.14	0.52	0.21
Leasehold Improvements	12.69	12.5	9.21	6.66	3.39	1.69

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q